Join Joanna Shields, CEO at BenevolentAI and Jo Holbrook, VP Translational medicine at CogX event that will be held in London.
Joanna is a tech industry veteran with over 25 years' experience building and scaling global companies including Facebook, Bebo, Aol, Google, Real Networks and Efi. Prior to joining Benevolent AI, she served in UK Government as Under Secretary of State and Minister for Internet Safety & Security, Digital Economy Adviser and Chair and CEO of TechCityUK. Joanna is passionate about creating responsible technology that benefits humanity. She is a leading advocate for children's rights and safety online and founder of the WeProtect Global Alliance.
The Future of Drug Discovery and Hard to Treat Diseases Panel
Noor Shaker, GTN
Jo Holbrook, BenevolentAI
Alex Zhavoronokov, CEO, Insilico
Bhavagaya Bakshi, C the Signs
Mark Caulfield, Director, Genomics England
Jo is VP Translational Medicine at BenevolentAI. She has PhD in molecular biology. 10 years in drug discovery and development at GSK, in the UK (neurology) and US (oncology). Led a large biomolecular informatics group at Singapore Institute for Clinical Sciences (A*STAR, Singapore) investigating epigenomic markers of complex disease progression and interventional efficacy, in observational and interventional cohorts. Professor of Bioinformatics in the faculty of medicine at University of Southampton (NIHR BRC), led efforts to integrate NHS data into University Research cohorts. Played a leading role in the Epigen global academic consortia (UK, NZ, Singapore) delivering major scientific projects within industry alliances. Visiting professor at University of Southampton.